Teva Agrees to Specify Executive Pay as Lawsuit Settled

Teva Pharmaceutical Industries Ltd. agreed to publish individual executives’ pay, settling an investor class-action lawsuit filed in Tel Aviv that argued the company violated Israeli and U.S. rules for more than a decade.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.